Increased Risk of Hypertrophic Scarring in Estrogen Receptor-positive Breast Cancer: a Bidirectional Mendelian Randomization Study

Overview

Journal Arch Dermatol Res

Date 2025 Jan 20

PMID 39833481

Authors

Yuchen Cao

Chunjun Liu

Affiliations

Soon will be listed here.

Abstract

Breast cancer (BC) is a prevalent malignancy in women, often necessitating tumor resection and breast reconstruction surgeries. However, the post-operation scars can be of concern, as hypertrophic scars (HS) can profoundly impact patients' quality of life. Our study used the bidirectional Mendelian randomization (MR) method to explore the potential relationship between BC and HS. We conducted a comprehensive genetic analysis using a large meta-analysis dataset comprising the BCAC, FinnGen, MRC-IEU, and GTEx eQTL datasets. We identified independent genetic loci associated with BC and HS among individuals of European ancestry. These loci served as instrumental variables (SNPs) in MR analysis. We used the inverse-variance weighted and weighted median methods, with the odds ratio (OR) as the effect measure, to investigate the causal relationship between breast disease and HS, and all significance was corrected by FDR and Bonferroni. We assessed heterogeneity and horizontal pleiotropy through Cochran's Q, MR-PRESSO, and MR-Egger intercept tests. Moreover, a leave-one-out sensitivity analysis was performed to evaluate the impact of individual SNPs on the MR study. The MR analysis showed a significant positive association between BC and HS (OR = 1.31, 95% CI 1.10-1.56, P = 0.002). However, there was no significant association between benign breast neoplasm and HS (OR = 0.97, P = 0.73). Subgroup analysis of BC revealed that estrogen receptor-positive (ER) BC increased the risk of HS (OR = 1.32, 95% confidence interval: 1.11-1.57, P = 0.0016), while ER-negative (ER) BC did not increase the risk of HS (OR = 0.99, P = 0.91). Analysis of the GTEx database demonstrated that increased ER level alone in healthy individuals (n = 3301) did not increase the risk of HS (P = 0.42). This result was well replicated in two independent HS datasets, and the causal effect of BC on HS was unidirectional. BC is positively associated with the incidence of HS, especially in the case of ERBC. However, there is a lack of substantial evidence regarding the relationship between ERBC and HS.

References

Taylor C, McGale P, Probert J, Broggio J, Charman J, Darby S . Breast cancer mortality in 500 000 women with early invasive breast cancer diagnosed in England, 1993-2015: population based observational cohort study. BMJ. 2023; 381:e074684. PMC: 10261971. DOI: 10.1136/bmj-2022-074684. View

Jeevan R, Cromwell D, Browne J, Caddy C, Pereira J, Sheppard C . Findings of a national comparative audit of mastectomy and breast reconstruction surgery in England. J Plast Reconstr Aesthet Surg. 2014; 67(10):1333-44. DOI: 10.1016/j.bjps.2014.04.022. View

Roder D, Zorbas H, Kollias J, Pyke C, Walters D, Campbell I . Factors predictive of immediate breast reconstruction following mastectomy for invasive breast cancer in Australia. Breast. 2013; 22(6):1220-5. DOI: 10.1016/j.breast.2013.09.011. View

Zehnpfennig L, Ritter M, Montagna G, Handschin T, Ling B, Oberhauser I . The impact of delayed wound healing on patient-reported outcomes after breast cancer surgery. J Plast Reconstr Aesthet Surg. 2022; 75(11):4125-4132. DOI: 10.1016/j.bjps.2022.06.106. View

Spira J, Borges E, Silva P, Abreu M, Guedes A, Pires-Junior J . Factors associated with complex surgical wounds in breast and abdomen: a case-control observational study. Rev Lat Am Enfermagem. 2018; 26:e3052. PMC: 6201706. DOI: 10.1590/1518-8345.2274.3052. View

Burstein H . Systemic Therapy for Estrogen Receptor-Positive, HER2-Negative Breast Cancer. N Engl J Med. 2020; 383(26):2557-2570. DOI: 10.1056/NEJMra1307118. View

Timmermans F, Westland P, Hummelink S, Schreurs J, Hameeteman M, Ulrich D . A retrospective investigation of abdominal visceral fat, body mass index (BMI), and active smoking as risk factors for donor site wound healing complications after free DIEP flap breast reconstructions. J Plast Reconstr Aesthet Surg. 2018; 71(6):827-832. DOI: 10.1016/j.bjps.2018.03.003. View

Hart A, Funderburk C, Chu C, Pinell-White X, Halgopian T, Manning-Geist B . The Impact of Diabetes Mellitus on Wound Healing in Breast Reconstruction. Ann Plast Surg. 2016; 78(3):260-263. DOI: 10.1097/SAP.0000000000000881. View

Modarressi A, Muller C, Montet X, Ruegg E, Pittet-Cuenod B . DIEP flap for breast reconstruction: Is abdominal fat thickness associated with post-operative complications?. J Plast Reconstr Aesthet Surg. 2017; 70(8):1068-1075. DOI: 10.1016/j.bjps.2017.05.002. View

10.

Michailidou K, Lindstrom S, Dennis J, Beesley J, Hui S, Kar S . Association analysis identifies 65 new breast cancer risk loci. Nature. 2017; 551(7678):92-94. PMC: 5798588. DOI: 10.1038/nature24284. View

11.

Kurki M, Karjalainen J, Palta P, Sipila T, Kristiansson K, Donner K . FinnGen provides genetic insights from a well-phenotyped isolated population. Nature. 2023; 613(7944):508-518. PMC: 9849126. DOI: 10.1038/s41586-022-05473-8. View

12.

Sun B, Maranville J, Peters J, Stacey D, Staley J, Blackshaw J . Genomic atlas of the human plasma proteome. Nature. 2018; 558(7708):73-79. PMC: 6697541. DOI: 10.1038/s41586-018-0175-2. View

13.

Azizi E, Carr A, Plitas G, Cornish A, Konopacki C, Prabhakaran S . Single-Cell Map of Diverse Immune Phenotypes in the Breast Tumor Microenvironment. Cell. 2018; 174(5):1293-1308.e36. PMC: 6348010. DOI: 10.1016/j.cell.2018.05.060. View

14.

Danenberg E, Bardwell H, Zanotelli V, Provenzano E, Chin S, Rueda O . Breast tumor microenvironment structures are associated with genomic features and clinical outcome. Nat Genet. 2022; 54(5):660-669. PMC: 7612730. DOI: 10.1038/s41588-022-01041-y. View

15.

Wuhrer A, Uhlig S, Tuschy B, Berlit S, Sperk E, Bieback K . Wound Fluid from Breast Cancer Patients Undergoing Intraoperative Radiotherapy Exhibits an Altered Cytokine Profile and Impairs Mesenchymal Stromal Cell Function. Cancers (Basel). 2021; 13(9). PMC: 8124792. DOI: 10.3390/cancers13092140. View

16.

Tarek A, El-Sayed S, Woodward W, El-Shinawi M, Hirshon J, Mohamed M . Inflammatory Breast Cancer: The Cytokinome of Post-Mastectomy Wound Fluid Augments Proliferation, Invasion, and Stem Cell Markers. Curr Issues Mol Biol. 2022; 44(6):2730-2744. PMC: 9222108. DOI: 10.3390/cimb44060187. View

17.

Zhou Q, Wu X, Hu J, Yuan R . Abnormal expression of fibrosis markers, estrogen receptor α and stromal derived factor‑1/chemokine (C‑X‑C motif) receptor‑4 axis in intrauterine adhesions. Int J Mol Med. 2018; 42(1):81-90. PMC: 5979937. DOI: 10.3892/ijmm.2018.3586. View

18.

Sun X, Xue M, Deng X, Lin Y, Tan Y, Wei X . Clinical characteristic and intraoperative findings of uterine perforation patients in using of intrauterine devices (IUDs). Gynecol Surg. 2018; 15(1):3. PMC: 5770510. DOI: 10.1186/s10397-017-1032-2. View

19.

Gabbiani G, Hirschel B, RYAN G, Statkov P, Majno G . Granulation tissue as a contractile organ. A study of structure and function. J Exp Med. 1972; 135(4):719-34. PMC: 2139162. DOI: 10.1084/jem.135.4.719. View

20.

Hosokawa M, Ishii M, Inoue K, Yao C, Takeda T . Estrogen induces different responses in dermal and lung fibroblasts: special reference to collagen. Connect Tissue Res. 1981; 9(2):115-20. DOI: 10.3109/03008208109160249. View